NCT06805474View on ClinicalTrials.gov

A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 28, 2025

Primary Completion Date

May 20, 2025

Study Completion Date

May 27, 2025

Conditions
Macular DegenerationGeographic AtrophyStargardt Disease
Interventions
OTHER

Observational

Observational

Trial Locations (1)

75243

RECRUITING

Retina of North Texas,, Dallas

Sponsors
All Listed Sponsors
lead

Nanoscope Therapeutics Inc.

INDUSTRY